A crowd the size of a sold-out Foo Fighters stadium show, some 40,000-plus physicians, researchers, industry executives and patients, will gather in Chicago at the end of this week for the world's biggest cancer conference. The data, as always, will be the headline act. This year, for the first time, the plenary slot belongs to China.
13 min read
Tuesday
Trial Tuesday: China's ASCO Moment
For the first time in ASCO's history, China-only data occupies the plenary slot. A hazard ratio of 0.40 in pancreatic cancer. And Lilly moving the obesity ceiling above bariatric surgery. Chicago has a lot to answer for this week.
